Effect of chronic administration of ketamine on the mitochondrial respiratory chain activity caused by chronic mild stress

Acta Neuropsychiatrica

Volumn 22, Issue 6, 2010, Pages 292-299

  Rezin, Gislaine T ^a,b   Gonçalves, Cinara L ^a,b   Daufenbach, Juliana F ^a,b   Carvalho Silva, Milena ^a,b   Borges, Lislaine S ^a,b   Vieira, Julia S ^a,b   Hermani, Fernanda V ^a,b   Comim, Clarissa M ^a,b   Quevedo, João ^a,b   Streck, Emilio L ^a,b  

^a UNIVERSIDADE DO EXTREMO SUL CATARINENSE   (Brazil)

^b Instituto Nacional de Ciência e Tecnologia Translacional Em Medicina   (Brazil)

Author keywords

brain; chronic mild stress; ketamine; mitochondrial respiratory chain

Indexed keywords

CYTOCHROME C OXIDASE; KETAMINE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); UBIQUINOL CYTOCHROME C REDUCTASE;

ADRENAL GLAND; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BRAIN CORTEX; CEREBELLUM; CHRONIC DRUG ADMINISTRATION; CHRONIC STRESS; CONTROLLED STUDY; ENZYME INHIBITION; FOOD INTAKE; MALE; MITOCHONDRIAL RESPIRATION; NONHUMAN; RAT;

EID: 78349243715     PISSN: 09242708     EISSN: 16015215     Source Type: Journal    
DOI: 10.1111/j.1601-5215.2010.00500.x     Document Type: Article

References (41)

1. Kessler RC, McGonagle KA, Zhao S, et al., Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 1994; 51: 8-19.
2. Mueller TI, Leon AC, Keller MB, et al., Recurrence after recovery from major depressive disorder during 15 years of observational followup. Am J Psychiatry 1999; 156: 1000-1006.
3. Mann JJ., The medical management of depression. N Engl J Med 2005; 353: 1819-1834.
4. Skolnick P, Popik P, Janowsky A, Beer B, Lippa AS., 'Broad spectrum' antidepressants: is more better for the treatment of depression?. Life Sci 2003; 73: 3175-3179.
5. Skolnick P., Antidepressants for the new millennium. Eur J Pharmacol 1999; 375: 31-40.
6. Nutt DJ., The neuropharmacology of serotonin and noradrenaline in depression. Int Clin Psychopharmacol 2002; 17: S1-S12.
7. Javitt DC., Glutamate as a therapeutic target in psychiatric disorders. Mol Psychiatry 2004; 9: 984-997.
8. Krystal JH, D'Souza DC, Petrakis IL, et al., NMDA agonists and antagonists as probes of glutamatergic dysfunction and pharmacotherapies in neuropsychiatric disorders. Harv Rev Psychiatry 1999; 7: 125-143.
9. Danysz W, Parsons CG., The NMDA receptor antagonist memantine as a symptomatological and neuroprotective treatment for Alzheimer's disease: preclinical evidence. Int J Geriatr Psychiatry 2003; 18: S23-S32.
10. Hirota K, Lambert DJ., Ketamine: its mechanism(s) of action and unusual clinical uses. Br J Anaesth 1996; 77: 441-444.
11. Murck H, Schubert MI, Schmid D, Schüssler P, Steiger A, Auer DP., The glutamatergic system and its relation to the clinical effect of therapeutic-sleep deprivation in depression an MR spectroscopy study. J Psychiatr Res 2009; 43: 175-180.
12. Kanarik M, Matrov D, Kšiv K, Eller M, Tšnissaar M, Harro J., Changes in regional long-term oxidative metabolism induced by partial serotonergic denervation and chronic variable stress in rat brain. Neurochem Int 2008; 52: 432-437.
13. Stanyer L, Jorgensen W, Hori O, Clark JB, Heales SJ., Inactivation of brain mitochondrial Lon protease by peroxynitrite precedes electron transport chain dysfunction. Neurochem Int 2008; 53: 95-101.
14. Boekema EJ, Braun HP., Supramolecular structure of the mitochondrial oxidative phosphorylation system. J Biol Chem 2007; 282: 1-4.
15. Rezin GT, Amboni G, Zugno AI, Quevedo J, Streck EL., Mitochondrial dysfunction and psychiatric disorders. Neurochem Res 2009; 34: 1021-1029.
16. Rezin GT, Cardoso MR, Gonçalves CL, et al., Inhibition of mitochondrial respiratory chain in brain of rats subjected to an experimental model of depression. Neurochem Int 2008; 53: 395-400.
17. Gamaro GD, Manoli LP, Torres IL, Silveira R, Dalmaz C., Effects stress on feeding behaviour and on monoamine levels in structures. Neurochem Int 2003; 42: 107-114.
18. Rezin GT, Gonçalves CL, Daufenbach JF, et al., Acute administration of ketamine reverses the inhibition of mitochondrial respiratory chain induced by chronic mild stress. Brain Res Bull 2009; 79: 418-421.
19. Ely DR, Dapper V, Marasca J, et al., Effect of restraint stress on feeding behavior of rats. Physiol Behav 1997; 61: 395-398.
20. Katz RJ., Animal model of depression: pharmacological sensitivity of a hedonic deficit. Pharmacol Biochem Behav 1981; 16: 965-968.
21. Lowry OH, Rosebough NG, Farr AL, Randall RJ., Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-275.
22. Cassina A, Radi R., Differential inhibitory action of nitric oxide and peroxynitrite on mitochondrial electron transport. Arch Biochem Biophys 1996; 328: 309-316.
23. Fischer JC, Ruitenbeek W, Berden JA, et al., Differential investigation of the capacity of succinate oxidation in human skeletal muscle. Clin Chim Acta 1985; 153: 23-26.
24. Rustin P, Chretien D, Bourgeron T, et al., Biochemical and molecular investigations in respiratory chain deficiencies. Clin Chim Acta 1994; 228: 35-51.
25. Konarska M, Stewart RE, McCarty R., Predictability of chronic intermittent stress: effects on sympathetic-adrenal medullary responses of laboratory rats. Behav Neural Biol 1990; 53: 231-243.
26. Harro J, Tonissaar M, Eller M, Kask A, Oreland L., Chronic variable stress and partial 5-HT denervation by parachloroamphetamine treatment in the rat: effects on behavior and monoamine neurochemistry. Brain Res 2001; 899: 227-239.
27. Burns GA, Ritter RC., Visceral afferent participation in delayed satiation following NMDA receptor blockade. Physiol Behav 1998; 65: 361-366.
28. Treece BR, Ritter RC, Burns GA., Lesions of the dorsal vagal complex abolish increases in meal size induced by NMDA receptor blockade. Brain Res 2008; 72: 37-43.
29. O'Connor TM, O'Halloran DJ, Shanahan F., The stress response and the hypothalamic-pituitary-adrenal axis: from molecule to melancholia. Q J Med 2000; 93: 323-333.
30. Bekris S, Antoniou K, Daskas S, PapadopoulouDaifoti Z., Behavioural and neurochemical effects induced by chronic mild stress applied to two different rat strains. Behav Brain Res 2005; 161: 45-59.
31. Wilner P., Chronic mild stress (CMS) revisited: consistency and behavioral-neurobiological concordance in the effects of CMS. Neuropsychobiology 2005; 52: 90-110.
32. Gardner A, Johansson A, Wibom R, et al., Alterations of mitochondrial function and correlations with personality traits in selected major depressive disorder patients. J Affect Disord 2003; 76: 55-68.
33. Madrigal JLM, Olivenza R, Moro MA, et al., Glutathione depletion, lipid peroxidation and mitochondrial dysfunction are induced by chronic stress in rat brain. Neuropsychopharmacol 2001; 24: 420-429.
34. Assis LC, Rezin GT, Comim CM, et al., Effect of acute administration of ketamine and imipramine on creatine kinase activity in the brain of rats. Rev Bras Psiquiatr 2009; 31: 247-252.
35. Berman RM, Cappiello A, Anand A, et al., Antidepressant effects of ketamine in depressed patients. Biol Psychiatry 2000; 47: 351-354.
36. Zarate CA Jr, Singh JB, Carlson, PJ, et al., A randomised trial of an N-methyl-d-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry 2006; 63: 856-864.
37. Zuo DY, Wu YL, Yao WX, Cao Y, Wu CF, Tanaka M., Effect of MK-801 and ketamine on hydroxyl radical generation in the posterior cingulate and retrosplenial cortex of free-moving mice, as determined by in vivo microdialysis. Pharmacol Biochem Behav 2007; 86: 1-7.
38. Saricaoglu F, Dal D, Salman AE, Doral MN, Kilinc K, Aypar U., Ketamine sedation during spinal anesthesia for arthroscopic knee surgery reduced the ischemia-reperfusion injury markers. Anesth Analg 2005; 101: 904-909.
39. Arnaiz SL, Coronel MF, Boveris A., Nitric oxide, superoxide and hydrogen peroxide production in brain mitochondria after haloperidol treatment. Nitric Oxide 1999; 3: 235-243.
40. Vasconcellos AP, Nieto FB, Crema LM, et al., Chronic lithium treatment has antioxidant properties but does not prevent oxidative damage induced by chronic variate stress. Neurochem Res 2006; 3: 1141-1151.
41. Adam-Vizi V., Production of reactive oxygen species in brain mitochondria: contribution by electron transport chain and non-electron transport chain sources. Antioxid Redox Signal 2005; 7: 1140-1149.